276 related articles for article (PubMed ID: 19128838)
1. Inhibition of cancer cell growth by ruthenium(II) cyclopentadienyl derivative complexes with heteroaromatic ligands.
Helena Garcia M; Morais TS; Florindo P; Piedade MF; Moreno V; Ciudad C; Noe V
J Inorg Biochem; 2009 Mar; 103(3):354-61. PubMed ID: 19128838
[TBL] [Abstract][Full Text] [Related]
2. DNA interaction and cytotoxicity studies of new ruthenium(II) cyclopentadienyl derivative complexes containing heteroaromatic ligands.
Moreno V; Font-Bardia M; Calvet T; Lorenzo J; Avilés FX; Garcia MH; Morais TS; Valente A; Robalo MP
J Inorg Biochem; 2011 Feb; 105(2):241-9. PubMed ID: 21194624
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, structural characteristics, DNA binding properties and cytotoxicity studies of a series of Ru(III) complexes.
Tan C; Liu J; Chen L; Shi S; Ji L
J Inorg Biochem; 2008 Aug; 102(8):1644-53. PubMed ID: 18468690
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of half sandwich ruthenium(II) complexes with strong hydrogen bond acceptor ligands and their mechanism of action.
Das S; Sinha S; Britto R; Somasundaram K; Samuelson AG
J Inorg Biochem; 2010 Feb; 104(2):93-104. PubMed ID: 19913918
[TBL] [Abstract][Full Text] [Related]
5. Heteroleptic arene ruthenium complexes based on meso-substituted dipyrrins: synthesis, structure, reactivity, and electrochemical studies.
Yadav M; Singh AK; Maiti B; Pandey DS
Inorg Chem; 2009 Aug; 48(16):7593-603. PubMed ID: 19610658
[TBL] [Abstract][Full Text] [Related]
6. New π-arene ruthenium(II) piano-stool complexes with nitrogen ligands.
Grau J; Noe V; Ciudad C; Prieto MJ; Font-Bardia M; Calvet T; Moreno V
J Inorg Biochem; 2012 Apr; 109():72-81. PubMed ID: 22387934
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, crystal structure, cytotoxic activities and DNA-binding properties of new binuclear copper(II) complexes bridged by N,N'-bis(N-hydroxyethylaminoethyl)oxamide.
Jiang M; Li YT; Wu ZY; Liu ZQ; Yan CW
J Inorg Biochem; 2009 May; 103(5):833-44. PubMed ID: 19324417
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structure and biological evaluation of bis salicylaldehyde-4(N)-ethylthiosemicarbazone ruthenium(iii) triphenylphosphine.
Prabhakaran R; Kalaivani P; Jayakumar R; Zeller M; Hunter AD; Renukadevi SV; Ramachandran E; Natarajan K
Metallomics; 2011 Jan; 3(1):42-8. PubMed ID: 21132183
[TBL] [Abstract][Full Text] [Related]
9. Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes.
van Rijt SH; Hebden AJ; Amaresekera T; Deeth RJ; Clarkson GJ; Parsons S; McGowan PC; Sadler PJ
J Med Chem; 2009 Dec; 52(23):7753-64. PubMed ID: 19791745
[TBL] [Abstract][Full Text] [Related]
10. Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms.
Vock CA; Ang WH; Scolaro C; Phillips AD; Lagopoulos L; Juillerat-Jeanneret L; Sava G; Scopelliti R; Dyson PJ
J Med Chem; 2007 May; 50(9):2166-75. PubMed ID: 17419606
[TBL] [Abstract][Full Text] [Related]
11. Anticancer activity of hydrogen-bond-stabilized half-sandwich Ru(II) complexes with heterocycles.
Mitra R; Das S; Shinde SV; Sinha S; Somasundaram K; Samuelson AG
Chemistry; 2012 Sep; 18(39):12278-91. PubMed ID: 22903299
[TBL] [Abstract][Full Text] [Related]
12. DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media.
Novakova O; Chen H; Vrana O; Rodger A; Sadler PJ; Brabec V
Biochemistry; 2003 Oct; 42(39):11544-54. PubMed ID: 14516206
[TBL] [Abstract][Full Text] [Related]
13. Half-sandwich Ru II[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: preparation, structural characterization and in vitro cytotoxic activity.
Bratsos I; Jedner S; Bergamo A; Sava G; Gianferrara T; Zangrando E; Alessio E
J Inorg Biochem; 2008; 102(5-6):1120-33. PubMed ID: 18279961
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of organometallic ruthenium(II) complexes with strong activity against several human cancer cell lines.
Morais TS; Silva TJ; Marques F; Robalo MP; Avecilla F; Amorim Madeira PJ; Mendes PJ; Santos I; Garcia MH
J Inorg Biochem; 2012 Sep; 114():65-74. PubMed ID: 22698866
[TBL] [Abstract][Full Text] [Related]
15. A novel ruthenium(II) arene based intercalator with potent anticancer activity.
Ruiz J; Vicente C; de Haro C; Bautista D
Dalton Trans; 2009 Jul; (26):5071-3. PubMed ID: 19562164
[TBL] [Abstract][Full Text] [Related]
16. Three new Cu(II) and Cd(II) complexes with 3-(2-pyridyl)pyrazole-based ligand: syntheses, crystal structures, and evaluations for bioactivities.
Chen R; Liu CS; Zhang H; Guo Y; Bu XH; Yang M
J Inorg Biochem; 2007 Mar; 101(3):412-21. PubMed ID: 17222454
[TBL] [Abstract][Full Text] [Related]
17. Studies of the mechanism of action of platinum(II) complexes with potent cytotoxicity in human cancer cells.
Krause-Heuer AM; Grünert R; Kühne S; Buczkowska M; Wheate NJ; Le Pevelen DD; Boag LR; Fisher DM; Kasparkova J; Malina J; Bednarski PJ; Brabec V; Aldrich-Wright JR
J Med Chem; 2009 Sep; 52(17):5474-84. PubMed ID: 19658404
[TBL] [Abstract][Full Text] [Related]
18. Cyclopentadienyl-ruthenium(II) and iron(II) organometallic compounds with carbohydrate derivative ligands as good colorectal anticancer agents.
Florindo PR; Pereira DM; Borralho PM; Rodrigues CM; Piedade MF; Fernandes AC
J Med Chem; 2015 May; 58(10):4339-47. PubMed ID: 25923600
[TBL] [Abstract][Full Text] [Related]
19. Tetranuclear coordination assemblies based on half-sandwich ruthenium(II) complexes: noncovalent binding to DNA and cytotoxicity.
Linares F; Galindo MA; Galli S; Romero MA; Navarro JA; Barea E
Inorg Chem; 2009 Aug; 48(15):7413-20. PubMed ID: 19586019
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, antitumor activity and structure-activity relationships of a series of Ru(II) complexes.
Liu J; Zheng W; Shi S; Tan C; Chen J; Zheng K; Ji L
J Inorg Biochem; 2008 Feb; 102(2):193-202. PubMed ID: 17825915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]